Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Special Report 3 Stocks Under $5 With Strong Analyst Upside PotentialBy Chris Markoch. Article Published: 2/24/2026. 
Key Points - Grab Holdings is gaining analyst support as revenue growth and its first full year of profitability highlight long-term opportunity in Southeast Asia’s expanding digital economy.
- Vaxart offers speculative biotech upside with its oral vaccine platform targeting influenza, norovirus, and COVID-19, creating a high-risk, high-reward setup.
- ThredUp is positioned to benefit from the fast-growing resale market, with strong institutional ownership and industry forecasts pointing to sustained secondhand demand.
- Special Report: [Sponsorship-Ad-6-Format3]
While many investors are rotating out of speculative penny stocks, others continue to embrace their risk-reward dynamic. Stocks that trade for under $5 carry inherent risk: many of these companies are unprofitable, and some generate little to no revenue. In almost every case these are small-cap companies. Small caps have been beaten up in recent years, and even though the Russell 2000 shows some signs of recovery, that strength hasn't translated across the broader small-cap sector. I Called Black Monday. Now I'm Calling March 26!
I predicted the 1987 crash six weeks early. I called the fall of the Berlin Wall. I pinpointed the exact bottom in 2009.
Now I'm staking my reputation on March 26, 2026 - the day I believe Elon will announce the SpaceX IPO.
Bloomberg is calling it "the biggest listing of ALL TIME."
A $1.5 TRILLION valuation... the "wealth-building" moment of the decade.
Today, I'll show you how to get in before the big announcement. Click Here to See How to Secure Your "SpaceX Access Code" That could change in 2026 if the economic outlook continues to improve. In that scenario, money may start to flow back into speculative names. As with any corner of the market, though, quality matters. One way to filter for quality is to look for stocks with positive analyst sentiment. That's true of the three names below. Each lets investors build a meaningful position with a modest outlay while still offering potential for significant upside over the next five years. Profitability Milestone Meets Long-Term Emerging Market Growth Emerging-market stocks are expected to be among the winners in 2026. That hasn't been the case so far for Grab Holdings Inc. (NASDAQ: GRAB), which is down roughly 15% year-to-date. Grab, based in Singapore, operates a super app that blends technology, e-commerce and fintech services. One reason behind the stock's recent pullback is its proposed merger with Indonesian ride-hailing competitor GoTo. The deal is not final and could be affected by significant legislative changes in Indonesia that would limit the company's earnings potential there. The company also slightly missed the top line in its Q4 2025 earnings report. Some context is important: revenue rose 19% year-over-year, and the period marked Grab's first full year of profitability. Analysts are forecasting roughly 120% earnings growth over the next 12 months. That helps explain why sentiment remains bullish. GRAB stock has a consensus price target of $6.47, roughly 54% above its current level. High-Risk Biotech With Platform Potential Penny stock investors often look to the biotechnology sector, where balancing risk and reward is the norm. One company to watch is Vaxart Inc. (OTCMKTS: VXRT). It's the only name on this list that meets the classic definition of a penny stock — at the time of writing it was trading just over $0.60 a share. VXRT doesn't receive heavy analyst coverage, but the one analyst to issue a rating in the past 12 months rates it a Buy with a $2 price target. It's not uncommon for analysts to overlook some biotech firms. Vaxart is a clinical-stage company, meaning its vaccine candidates are still in clinical trials. The upside is clear: Vaxart is developing oral vaccines primarily for influenza, norovirus and COVID-19. Beyond convenience and avoiding needle-related hesitation, the company says its platform may induce a broader immune response, potentially offering wider protection. VXRT has only about 18% institutional ownership, but on a dollar-volume basis inflows outnumber outflows almost 10:1. Resale Tailwinds Could Turn Today's Losses Into Tomorrow's Gains ThredUp Inc. (NASDAQ: TDUP) is down about 33% year-to-date in 2026, but a longer view offers a different perspective. Over the past 12 months TDUP is up more than 66%, suggesting the recent decline may simply be a normal pullback as investors avoid companies that aren't yet profitable. In ThredUp's case "not profitable — yet" may apply. The company operates an online consignment and thrift platform that's gaining traction with Gen Z, and its revenue reflects that: in the most recent quarter, revenue rose 12.5% year-over-year. ThredUp cites a GlobalData 2025 market survey that forecasted the U.S. secondhand market's gross merchandise value would grow at a compound annual growth rate (CAGR) of 9% through 2029. Institutional investors own an impressive 89% of the stock. Buying has outpaced selling by about two to one on a dollar basis and three to one by number of trades. That said, short interest sits near 17%, which can add short-term volatility. The consensus price target from six analysts is $12.50, which would represent more than a 190% increase from its price at the time of writing.
| 
